Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026
DXP Enterprises (DXPE.O, NASDAQ Cons)
Závěr k 13.2.2026 Změna (%) Změna (USD) Objem obchodů (USD)
148,55 4,31 6,14 9 480 300
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 15.02.2026
Popis společnosti

Business Summary: DXP Enterprises, Inc. is a products and service distributor. The Company serves industrial customers throughout the United States, Canada, and Dubai. The Company's segments include Service Centers, Innovative Pumping Solutions and Supply Chain Services. The Company's Service Centers segment provides a range of maintenance, repair and operating (MRO) products and services in the rotating equipment, bearing, power transmission, hose, fluid power, metal working, industrial supply and safety product and service categories. The Company's Innovative Pumping Solutions segment provides products and services to the water and wastewater market and fabricates and assembles integrated pump system packages custom made to customer specifications, remanufactures pumps, and manufactures branded private label pumps. The Company's Supply Chain Services segment provides a range of MRO products and manages all or part of its customers' supply chain function, and inventory management.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, DXP Enterprises Inc revenues increased 12% to $1.49B. Net income applicable to common stockholders increased 34% to $65.8M. Revenues reflect Service Centers segment increase of 12% to $1.02B, Innovative Pumping Solutions segment increase of 24% to $280.3M. Net income benefited from Corporate expenses segment loss decrease of 25% to $59.4M, Service Centers segment income increase of 14% to $148.6M.



  • Poslední aktualizace: 15.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Executive Co-Chairman of the Board, President, Chief Executive OfficerZeeshan Saeed5504.07.202325.05.2018
Co-Executive Chairman of the BoardAnthony Durkacz4904.07.202318.06.2018
Chief Financial OfficerDonal Carroll4930.08.202423.07.2018
Chief Executive Officer of Lucid, Director, President of FSD Biosciences and CEO of FSD AustraliaLakshmi Kotra5425.11.202225.11.2022
Vice President - Clinical and Scientific AffairsAndrzej Chruscinski-
Director of Pharmaceutical DevelopmentAshwini Joshi,-01.01.2024